VIH1D Stock Overview
A real estate holding company, develops, buys, holds, rents, and manages commercial real estate properties in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
VIB Vermögen AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €9.92 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 0.99 |
| 11 Month Change | 0% |
| 3 Month Change | -7.64% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | -62.99% |
| Change since IPO | -54.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| VIH1D | GB Real Estate | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.7% | 0.8% |
| 1Y | n/a | 4.8% | 6.6% |
Return vs Industry: Insufficient data to determine how VIH1D performed against the UK Real Estate industry.
Return vs Market: Insufficient data to determine how VIH1D performed against the UK Market.
Price Volatility
| VIH1D volatility | |
|---|---|
| VIH1D Average Weekly Movement | n/a |
| Real Estate Industry Average Movement | 3.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: VIH1D has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VIH1D's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 41 | Dirk Oehme | www.vib-ag.de |
VIB Vermögen AG, a real estate holding company, develops, buys, holds, rents, and manages commercial real estate properties in Germany. The company’s real estate portfolio includes logistics and light industry properties, industrial real estate, shopping centers, and specialist retail parks, as well as commercial and service centers. It also manages properties of institutional investors.
VIB Vermögen AG Fundamentals Summary
| VIH1D fundamental statistics | |
|---|---|
| Market cap | €229.40m |
| Earnings (TTM) | €129.60m |
| Revenue (TTM) | €102.72m |
1.8x
P/E Ratio2.2x
P/S RatioIs VIH1D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VIH1D income statement (TTM) | |
|---|---|
| Revenue | €102.72m |
| Cost of Revenue | €17.94m |
| Gross Profit | €84.78m |
| Other Expenses | -€44.83m |
| Earnings | €129.60m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 27, 2024
| Earnings per share (EPS) | 3.92 |
| Gross Margin | 82.53% |
| Net Profit Margin | 126.17% |
| Debt/Equity Ratio | 106.1% |
How did VIH1D perform over the long term?
See historical performance and comparison